Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2014

View Archived Issues

Development of novel potent oxytocin receptor agonists to correct aberrant preterm lactation

Burnet Institute and Artes Biotechnology to develop new type of malaria vaccine

Pfizer reflects on achievements of second quarter 2014

AstraZeneca to acquire Almirall's respiratory business

AstraZeneca and Kyowa Hakko Kirin form clinical immuno-oncology collaboration

Roche and AmorChem collaborate in myotonic muscular dystrophy 1

Zealand Pharma and Boehringer Ingelheim collaborate in cardiometabolic disease

Immune Pharmaceuticals initiates phase II trial of bertilimumab in bullous pemphigoid

Novel Nrf2 pathway activator tested in animal model for treatment of ischemia-reperfusion injury

Piramal Enterprises designs novel agents for cancer

New compounds for bacterial infections disclosed by Actelion Pharmaceuticals

Promising preclinical results with anti-CD154 antibody BMS-986004 in kidney transplant models

Merck KGaA patents new piperidinylcarbazole derivatives for malaria

Gilead Sciences synthesizes novel antiretrovirals

Aurigene Discovery Technologies divulges novel BTK inhibitors

Phase II efficacy, safety and favorable pharmacometrics of TOL-101

Stivarga approved in the E.U. for gastrointestinal stromal tumors

Regeneron and Sanofi report topline data from nine phase III trials of alirocumab

Baxter divests commercial vaccines business to Pfizer

Incyte and Genzyme to evaluate combination of two novel cancer immunotherapies

New start-up Emulate to commercialize Wyss Institute's Organs-on-Chips technology

Amgen reveals milestones of second quarter 2014

Glide Pharmaceutical licenses rights from FScan to prostate cancer diagnostic technology

Angelini to commercialize dalbavancin in select European countries

Evotec identifies novel targets in Alzheimer's disease collaboration with Janssen

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...